Jeffrey A. Greenwood

Jeffrey A. Greenwood

Auto-generated profile, based on publicly available information

Jeffrey A. Greenwood

Oregon State University, Biochemistry and Biophysics Department, Corvallis, OR, USA

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Toxicology Reports
Verified
Journal Article
Open access
LWLeah Wehmas
Leah Wehmas
CACatherine Anders
Catherine Anders
JCJordan Chess
Jordan Chess
APAlex Punnoose
Alex Punnoose
CPCliff B. Pereira
Cliff B. Pereira
Robyn Leigh TanguayRobyn Leigh Tanguay
Robyn Leigh Tanguay
Engineered metal oxide nanoparticles (MO NPs) are finding increasing utility in the medical field as anticancer agents. Before validation of in vivo anticancer efficacy can occur, a better understanding of whole-animal toxicity is required. We compared the toxicity of seven widely used semiconductor MO NPs made from zinc oxide (ZnO), titanium dioxide, cerium dioxide and tin dioxide prepared in pure water and in synthetic seawater using a five-day embryonic zebrafish assay. We hypothesized that the toxicity of these engineered MO NPs would depend on physicochemical properties. Significant agglomeration of MO NPs in aqueous solutions is common making it challenging to associate NP characteristics such as size and charge with toxicity. However, data from our agglomerated MO NPs suggests that the elemental composition and dissolution potential are major drivers of toxicity. Only ZnO caused significant adverse effects of all MO particles tested, and only when prepared in pure water (point estimate median lethal concentration = 3.5–9.1 mg/L). This toxicity was life stage dependent. The 24 h toxicity increased greatly (∼22.7 fold) when zebrafish exposures started at the larval life stage compared to the 24 h toxicity following embryonic exposure. Investigation into whether dissolution could account for ZnO toxicity revealed high levels of zinc ion (40–89% of total sample) were generated. Exposure to zinc ion equivalents revealed dissolved Zn2+ may be a major contributor to ZnO toxicity.

7 August 2000 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
JGJeffrey A. Greenwood
Jeffrey A. Greenwood
ATAnne B. Theibert
Anne B. Theibert
GPGlenn D. Prestwich
Glenn D. Prestwich
JMJoanne E. Murphy-Ullrich
Joanne E. Murphy-Ullrich
Focal adhesions are an elaborate network of interconnecting proteins linking actin stress fibers to the extracellular matrix substrate. Modulation of the focal adhesion plaque provides a mechanism for the regulation of cellular adhesive strength. Using interference reflection microscopy, we found that activation of phosphoinositide 3-kinase (PI 3-kinase) by PDGF induces the dissipation of focal adhesions. Loss of this close apposition between the cell membrane and the extracellular matrix coincided with a redistribution of α-actinin and vinculin from the focal adhesion complex to the Triton X-100–soluble fraction. In contrast, talin and paxillin remained localized to focal adhesions, suggesting that activation of PI 3-kinase induced a restructuring of the plaque rather than complete dispersion. Furthermore, phosphatidylinositol (3,4,5)-trisphosphate (PtdIns (3,4,5)-P3), a lipid product of PI 3-kinase, was sufficient to induce restructuring of the focal adhesion plaque. We also found that PtdIns (3,4,5)-P3 binds to α-actinin in PDGF-treated cells. Further evidence demonstrated that activation of PI 3-kinase by PDGF induced a decrease in the association of α-actinin with the integrin β subunit, and that PtdIns (3,4,5)-P3 could disrupt this interaction in vitro. Modification of focal adhesion structure by PI 3-kinase and its lipid product, PtdIns (3,4,5)-P3, has important implications for the regulation of cellular adhesive strength and motility.

1 October 1995 in Experimental Cell Research
Verified
Journal Article
Closed access
JGJeffrey A. Greenwood
Jeffrey A. Greenwood
GJGail V.W. Johnson
Gail V.W. Johnson

6 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AHAndrew M. Hau
Andrew M. Hau
JGJeffrey A. Greenwood
Jeffrey A. Greenwood
CLChristiane V. Löhr
Christiane V. Löhr
JSJeffrey D. Serrill
Jeffrey D. Serrill
PPPhilip J. Proteau
Philip J. Proteau
Jane IshmaelJane Ishmael
Jane Ishmael
Coibamide A is an N-methyl-stabilized depsipeptide that was isolated from a marine cyanobacterium as part of an International Cooperative Biodiversity Groups (ICBG) program based in Panama. Previous testing of coibamide A in the NCI in vitro 60 cancer cell line panel revealed a potent anti-proliferative response and “COMPARE-negative” profile indicative of a unique mechanism of action. We report that coibamide A is a more potent and efficacious cytotoxin than was previously appreciated, inducing concentration- and time-dependent cytotoxicity (EC50<100 nM) in human U87-MG and SF-295 glioblastoma cells and mouse embryonic fibroblasts (MEFs). This activity was lost upon linearization of the molecule, highlighting the importance of the cyclized structure for both anti-proliferative and cytotoxic responses. We show that coibamide A induces autophagosome accumulation in human glioblastoma cell types and MEFs via an mTOR-independent mechanism; no change was observed in the phosphorylation state of ULK1 (Ser-757), p70 S6K1 (Thr-389), S6 ribosomal protein (Ser-235/236) and 4EBP-1 (Thr-37/46). Coibamide A also induces morphologically and biochemically distinct forms of cell death according to cell type. SF-295 glioblastoma cells showed caspase-3 activation and evidence of apoptotic cell death in a pattern that was also seen in wild-type and autophagy-deficient (ATG5-null) MEFs. In contrast, cell death in U87-MG glioblastoma cells was characterized by extensive cytoplasmic vacuolization and lacked clear apoptotic features. Cell death was attenuated, but still triggered, in Apaf-1-null MEFs lacking a functional mitochondria-mediated apoptotic pathway. From the study of ATG5-null MEFs we conclude that a conventional autophagy response is not required for coibamide A-induced cell death, but likely occurs in dying cells in response to treatment. Coibamide A represents a natural product scaffold with potential for the study of mTOR-independent signaling and cell death mechanisms in apoptotic-resistant cancer cells.

20 December 2011 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
SLSangeet Lal
Sangeet Lal
JDJane La Du
Jane La Du
RTRobert L. Tanguay
Robert L. Tanguay
JGJeffrey A. Greenwood
Jeffrey A. Greenwood

1 June 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TFTamara S. Fraley
Tamara S. Fraley
TTThuan C. Tran
Thuan C. Tran
ACAnne Marie Corgan
Anne Marie Corgan
CNCoral A. Nash
Coral A. Nash
JHJie Hao
Jie Hao
JGJeffrey A. Greenwood
Jeffrey A. Greenwood
α-Actinin is an abundant actin-bundling and adhesion protein that directly links actin filaments to integrin receptors. Previously, in platelet-derived growth factor-treated fibroblasts, we demonstrated that phosphoinositides bind to α-actinin, regulating its localization (Greenwood, J. A., Theibert, A. B., Prestwich, G. D., and Murphy-Ullrich, J. E. (2000) J. Cell Biol. 150, 627– 642). In this study, phosphoinositide binding and regulation of α-actinin function is further characterized. Phosphoinositide binding specificity, determined using a protein-lipid overlay procedure, suggests that α-actinin interacts with phosphates on the 4th and 5th position of the inositol head group. Binding assays and mutational analyses demonstrate that phosphoinositides bind to the calponin homology domain 2 of α-actinin. Phosphoinositide binding inhibited the bundling activity of α-actinin by blocking the interaction of the actin-binding domain with actin filaments. Consistent with these results, excessive bundling of actin filaments was observed in fibroblasts expressing an α-actinin mutant with decreased phosphoinositide affinity. We conclude that the interaction of α-actinin with phosphoinositides regulates actin stress fibers in the cell by controlling the extent to which microfilaments are bundled.